Seeing Is Believing
CMPI is currently covered by 1 analysts with an average price target of $4.39. This is a potential upside of $4.39 (0%) from yesterday's end of day stock price of $0.
Checkmate Pharmaceuticals's activity chart (see below) currently has 0 price targets and 2 ratings on display. The stock rating distribution of CMPI is 50% BUY and 50% HOLD.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 106.5 days.
Highest price target for CMPI is $10, Lowest price target is $3, average price target is $4.39.
Most recent stock forecast was given by KAVERI POHLMAN from BTIG on 20-Apr-2022. First documented stock forecast 06-Oct-2021.
Currently out of the existing stock ratings of CMPI, 1 are a BUY (50%), 1 are a HOLD (50%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
9
1 years 11 months 8 days ago
1/1 (100%)
$5.78 (179.50%)
20
Buy
7
$-3.5 (-33.33%)
2 years 5 months 20 days ago
1/1 (100%)
$2.99 (74.56%)
193
What is CMPI (Checkmate Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CMPI (Checkmate Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CMPI (Checkmate Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CMPI (Checkmate Pharmaceuticals)?
Which analyst is the currently most bullish on CMPI (Checkmate Pharmaceuticals)?
Which analyst is the currently most reserved on CMPI (Checkmate Pharmaceuticals)?